What Medacta International does

Medacta International SA is a Swiss orthopedic medical device company headquartered in Castel San Pietro, Switzerland, founded in 1999 by Dr. Alberto Siccardi, an orthopedic patient. The company designs, manufactures, and sells orthopedic implants, surgical instruments, and enabling technologies for hip, knee, and shoulder replacement, spine surgery, and sports medicine. Core franchises include the Quadra and AMIStem femoral stem families, GMK total and partial knee systems, the Medacta Shoulder System, the MOTO partial knee platform, and the VERS AFITCUP and MPACT acetabular lines, all anchored by the proprietary AMIS anterior minimally invasive surgery approach, the MectaGrip plasma-spray titanium coating, 3D Metal additive manufacturing, and the MySolutions personalized planning ecosystem (MyHip, MyKnee, MyShoulder, MySpine) paired with the Nextar mixed-reality navigation platform. The company serves orthopedic and spine surgeons, hospitals, and surgical centers across more than 70 countries through a direct sales model supported by regional offices in the Americas, Asia Pacific, Europe, and the Middle East & Africa, with surgeon adoption driven by the M.O.R.E. Institute global medical education platform, fellowship and mentorship programs, and the Medacta TV streaming service. Revenue is generated primarily through hardware sales of implants, instruments, bone cement, and coatings, with secondary revenue from medical education services, and the company is publicly listed on the SIX Swiss Exchange under ticker MTAX following its 2018 IPO. Financial scale as of FY2025 includes approximately €191 million in adjusted EBITDA at a 27.9% margin, operating cash flow of €152.7 million, and FY2026 constant currency revenue growth guidance of 10-14%, with mid-term guidance upgraded to 12-15%.

Name

Medacta International

Legal name

Medacta International SA

Website

https://medacta.com

Company type

Public

Founded year

1999

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Medacta International is a Swiss orthopedic medical device company that designs and sells joint replacement implants, spine, and sports medicine solutions, plus AR-enabled surgical navigation, to surgeons and hospitals in 70+ countries via direct sales and the M.O.R.E. Institute education platform.

Ownership category

akta.pro rank

Product category

Orthopedic Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA)

akta.pro secondary industries

Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL), Hip & Knee Reconstruction (Arthroplasty) (HLAKALAH)

Keywords

• Orthopedic implants
• Joint replacement devices
• Minimally invasive surgery
• Spine surgery products
• Patient-matched surgical planning

Headquarters

HQ city

Castel San Pietro

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Operations, Personnel, Marketing or Sales

Revenue model

1. Hip Replacement Products: Complete range of femoral stems (Quadra, AMIStem, SMS, Quadra-P), acetabular systems, and femoral heads for total hip replacement including primary and revision procedures.
2. Knee Replacement Products: Total knee systems (GMK Spherika, GMK Sphere, GMK Primary), partial knee systems (GMK UNI, MOTO Platform), and revision systems with patient-matched MyKnee technology.
3. Shoulder Replacement Products:
4. Spine Surgery Products: Cervical, MIS degenerative, and deformity spine surgery solutions with enabling technologies including MySpine and Nextar Spine.
5. Sports Medicine Products: Solutions for ACL/PCL reconstruction, meniscus repair, rotator cuff repair, labral repair, and distal extremities procedures.
6. Bone Cement and Advanced Materials: MectaCem bone cement, MectaGrip coating technology, and 3D Metal printing services for custom implants.
7. Medical Education Services: M.O.R.E. Institute education programs, fellowship, mentorship, and training services for surgeons.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels8 records

Core offering

Medacta International designs, manufactures, and markets orthopedic implants, surgical instruments, and enabling technologies for hip, knee, shoulder, and spine replacement as well as sports medicine procedures. Its portfolio includes femoral stems (Quadra, AMIStem, SMS, Quadra-P), acetabular cups (VERSAFITCUP, MPACT), knee systems (GMK SPHERE, GMK PRIMARY, GMK UNI, MOTO Platform), shoulder systems, spine solutions, bone cement (MectaCem), and MectaGrip and 3D Metal advanced materials. Complementing the hardware are patient-matched planning tools (MySolutions), robotic/AR navigation (Nextar), and the AMIS anterior minimally invasive surgical approach platform.

Product overview

Medacta International is a Swiss medical device company offering a comprehensive orthopedic and spine surgery portfolio. The product ecosystem centers on joint replacement solutions across hip, knee, and shoulder categories, supported by enabling technologies including patient-matched planning systems (MyKnee, MyHip, MyShoulder, MySpine), robotic-assisted surgery platform (Nextar), and the AMIS anterior surgical approach platform. Key product families include the Quadra System stem family (Quadra, Quadra-P, AMIStem, SMS) for hip replacement, GMK knee systems (SPHERE, SPHERIKA, PRIMARY, UNI, REVISION, MOTO Platform) for knee replacement, and the Medacta Shoulder System. These are complemented by acetabular systems (VERSAFITCUP, MPACT), bone cement (MectaCem X), and advanced materials (MectaGrip coating, 3D Metal). The M.O.R.E. Institute provides global medical education supporting the entire product portfolio.

Differentiator

Problem solved

Functional benefit

Brands

• AMIS: Anterior Minimally Invasive Surgery technique and platform developed by Medacta
• M.O.R.E. Institute
• MySolutions
• M.O.R.E. TV
• NEXTAR
• MyKA
• SENSITIN

Products and services

• Quadra System

Quantifiable outcome

• Over 20 years of clinical success with Quadra System stems demonstrating exceptionally good survival rates
• +2 more outcomes

Segments6 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Stryker: One of the Big-5 orthopedic incumbents and Medacta's most direct competitor across hip and knee implants and robotic-assisted surgery (Mako System). Comparable product breadth, hospital sales motion, and surgeon-education investment make Stryker the closest scale peer.
• Zimmer Biomet: Major orthopedic competitor overlapping across hip, knee, and sports medicine, and explicitly named as a key competitor in the AR surgical navigation market. Competes with Medacta through ROSA robotics, Persona knee, and a global direct salesforce.
• Smith+Nephew: Global orthopedic and sports medicine peer with hip/knee implant franchises and a robotics offering (CORI). Direct overlap with Medacta in joint reconstruction and sports medicine, particularly ACL/PCL reconstruction and meniscus repair.
• Johnson & Johnson (DePuy Synthes): Parent of DePuy Synthes, a leading orthopedic and spine franchise that competes across hip, knee, spine, and surgical navigation. Strong R&D budget and global salesforce represent the highest-scale competitive threat to Medacta.
• Conformis: Specialist in patient-specific knee implants, overlapping directly with Medacta's MyKnee patient-matched technology. Smaller and narrower than Medacta, but a focused competitor in personalized knee arthroplasty.
• Arthrex: Dominant sports medicine specialist whose ACL/PCL, meniscus, and rotator cuff portfolios directly overlap with Medacta's sports medicine segment. Private and highly surgeon-focused, comparable go-to-market through education and reference centers.
• Globus Medical: Spine-focused orthopedic peer that competes with Medacta's MySpine and Nextar Spine offerings. Combined with NuVasive, it is one of the largest pure-play spine companies and a direct peer in enabling technologies.
• Enovis (DJO): Orthopedic and sports medicine peer with hip/knee and extremities portfolios. Overlaps with Medacta in joint reconstruction and sports medicine, including reconstruction implants and surgical instrumentation.
• Brainlab: Surgical navigation and mixed-reality peer explicitly listed alongside Medacta as a key AR surgical navigation market player. Both companies develop AI-integrated AR solutions for spine, orthopedic, and neurosurgical applications.

Emerging players

• Augmedics: Emerging AR surgical navigation player (xvision system) competing with Medacta's Nextar in spine. Smaller and earlier stage than Medacta but a focused competitor in AR-guided spinal procedures.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/medacta
• YouTubeyoutube.com/user/MedactaInternational
• LinkedInlinkedin.com/company/medacta-international

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medacta International